Medical technology company Teleflex (NYSE: TFX) will be reporting earnings this Thursday morning. Here’s what to expect.
Teleflex beat analysts’ revenue expectations last quarter, reporting revenues of $548.3 million, up 32.3% year on year. It was a mixed quarter for the company, with a beat of analysts’ EPS estimates but a significant miss of analysts’ full-year EPS guidance estimates.
Is Teleflex a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Teleflex’s revenue to grow 26.4% year on year, a reversal from the 42% decrease it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Teleflex has missed Wall Street’s revenue estimates multiple times over the last two years.
Looking at Teleflex’s peers in the surgical equipment & consumables - specialty segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Intuitive Surgical delivered year-on-year revenue growth of 18.5%, beating analysts’ expectations by 2.5%, and Integra LifeSciences reported flat revenue, in line with consensus estimates. Intuitive Surgical traded down 14.1% following the results while Integra LifeSciences was also down 13.4%.
Read our full analysis of Intuitive Surgical’s results here and Integra LifeSciences’s results here.
Investors in the surgical equipment & consumables - specialty segment have had steady hands going into earnings, with share prices up 1.4% on average over the last month. Teleflex is up 5.5% during the same time and is heading into earnings with an average analyst price target of $149.45 (compared to the current share price of $141.68).
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
